Sort
11,323 grants matching “glioblastoma”
Nanocage-based systemic delivery of TGFb trap for immunomodulation of brain neoplasms
$419,968Jung Soo Suk · University Of Maryland Baltimore · R01 · FY2024 · NS
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC
$419,852Kwon-Sik Park · University Of Virginia · U01 · FY2019 · CA
Targeting IDH mutations to improve seizure control in glioma patients
$419,486Craig Michael Horbinski · Northwestern University At Chicago · R01 · FY2024 · NS
Microfluidics Array Based Sorting, Isolation, and RNA Analysis in Single Extracellular V csicles
$419,379Eduardo Reategui · Ohio State University · UG3 · FY2020 · TR
Optimization of delivery of HEX for treatment of primary amebic encephalitis
$419,375James Culvin Morris · Clemson University · R21 · FY2025 · TR
Redox homeostasis in IDH-mutant glioma progression
$419,375L. Eric Huang · University Of Utah · R21 · FY2019 · NS
Blood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastoma
$419,323Adam M Sonabend · Northwestern University At Chicago · R01 · FY2020 · CA
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
$419,275Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mouse models of glioma to study functional exRNA transfer to the microenvironmen
$419,247Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2017 · CA
Intranasal Stem-Cell Based Therapy for Glioblastoma
$419,228Maciej S Lesniak · University Of Chicago · R01 · FY2014 · NS
Intranasal Stem-Cell Based Therapy for Glioblastoma
$419,228Maciej S Lesniak · University Of Chicago · R01 · FY2015 · NS
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$419,152John H Sampson · Duke University · R01 · FY2014 · NS
Therapy Evaluation Core
$419,141Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2024 · CA
Topology-based tumor analysis for medical images
$419,076Chul Moon · Southern Methodist University · R15 · FY2023 · CA
Immobilized Drug Transporters
$419,067Irving William Wainer · National Institute On Aging · ZIA · FY2012 · AG
How does EGFR facilitate the constitutive activation of STAT3 in tumors?
$418,801George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · CA
INTERACTIONS OF FIBRINOGEN WITH p75NTR
$418,800Katerina Akassoglou · J. David Gladstone Institutes · R01 · FY2009 · NS
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms
$418,800Deliang Guo · Ohio State University · R01 · FY2024 · CA
Integrating miR-107 into signaling pathways that coordinate neurogenesis and brain vascular permeability
$418,750Stefania Nicoli · Yale University · R01 · FY2018 · HL
Integrating miR-107 into signaling pathways that coordinate neurogenesis and brain vascular permeability
$418,750Stefania Nicoli · Yale University · R01 · FY2020 · HL
Integrating miR-107 into signaling pathways that coordinate neurogenesis and brain vascular permeability
$418,750Stefania Nicoli · Yale University · R01 · FY2017 · HL
Integrating miR-107 into signaling pathways that coordinate neurogenesis and brain vascular permeability
$418,750Stefania Nicoli · Yale University · R01 · FY2019 · HL
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer
$418,750Susan E Gueble · Yale University · DP5 · FY2025 · OD
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer
$418,750Susan E Gueble · Yale University · DP5 · FY2024 · OD
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer
$418,750Susan E Gueble · Yale University · DP5 · FY2023 · OD